FDA Approved Allergan’s New Silicone Gel-Filled Breast Implant
You may have seen Dr. Elliott’s previous blog about Sientra’s FDA approved silicone gel-filled breast implant. Now, the Food and Drug Administration (FDA) has approved another highly cohesive silicone gel-filled implant manufactured by Allergan, Inc.
The Natrelle® 410 breast implants are approved for women over the age of 22 who would like to increase their breast size or seek to rebuild their breasts after trauma or illness with breast reconstruction. Over a seven year period, extensive research and data was collected from 941 women to ensure safety.
These silicone gel implants may provide a firmer, natural-looking result than previous silicone breast implants. As with any surgical procedure, Dr. Elliott thoroughly discusses realistic expectations and concerns patients may have. Allergan will also conduct post-approval studies to assess long-term safety and effectiveness.
Similar to the more commonly known silicone and saline breast implants, cohesive gel-filled implants can be placed under or above the chest muscle. These implants also come in different sizes and textures. The advantage of cohesive gel implants is their ability to better maintain their shape after trauma or rupture. With more options now available for breast augmentation, Dr. Elliott encourages all of his patients to conduct their research and discuss with a board-certified plastic surgeon their breast augmentation and breast reconstruction with implant options.
For more information about breast procedures or other procedures Dr. Elliott offers, please call us to schedule a consultation. Connect with Dr. Franklyn Elliott on Facebook, Twitter and Google+ for the latest plastic and reconstructive news.